NCT04861454

Brief Summary

Brow ptosis is a common problem. internal browbexy and brassier suture are common surgical approach

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 27, 2021

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2024

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2024

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

3.5 years

First QC Date

April 19, 2021

Last Update Submit

November 16, 2023

Conditions

Keywords

blepharoplastybrowbexy

Outcome Measures

Primary Outcomes (1)

  • global aesthetic scale

    calculate scale score from score 1 exceptional improvement to 5 worsening patient

    1 year

Study Arms (1)

surgical

internal browbexy and brassier suture were done after blepharoplasty

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

At least 18 years with dermatochalasis

You may qualify if:

  • brow ptosis and dermatochalasis

You may not qualify if:

  • eyelid diseases and previous surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

INMC

Abu Dhabi, 46266, United Arab Emirates

RECRUITING

MeSH Terms

Conditions

Eyelid Diseases

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • tarek elhamaky, MD

    Benha University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

TAREK R ELHAMAKY, MD

CONTACT

TAREK ELHAMAKY

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 19, 2021

First Posted

April 27, 2021

Study Start

January 10, 2021

Primary Completion

July 10, 2024

Study Completion

July 20, 2024

Last Updated

November 18, 2023

Record last verified: 2023-11

Locations